Tag: Obesity
Remotely Delivered Weight-Loss Intervention Beneficial in Breast Cancer
Intervention induces significant weight loss across demographic and treatment factors in patients with breast cancer, BMI ≥27
MedDiet Plus Energy Reduction, Physical Activity Cuts Incidence of Type 2 Diabetes
Energy-reduced MedDiet plus physical activity and behavioral strategies for weight loss beneficial for individuals with overweight or obesity and metabolic syndrome
GLP-1 Receptor Agonist Use Linked to Reduced Overall Risk for Cancer in Adults With...
Significantly lower risks seen for endometrial cancer, ovarian cancer, meningioma; nonsignificantly increased risk seen for kidney cancer
Bariatric Surgery Linked to Improved IBD Outcomes in Patients With Obesity
For patients with inflammatory bowel disease and obesity, surgery linked to reduction in IBD-related outcomes
Increasing Sit-to-Stand Transitions Lowers BP in Postmenopausal Women
Postmenopausal women with overweight or obesity who increase sit-to-stand transitions have significant decrease in diastolic blood pressure within three months
New Weight Loss Pill From Eli Lilly Shows Promise in Early Study
Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults
A number of young adults eligible for GLP-1 RAs are uninsured
Polygenic Scores for BMI Can Improve Prediction of Future Obesity
Children with higher polygenic scores showed accelerated BMI gain from age 2.5 years to adolescence in ALSPAC study
Prediabetes Risk Doubled for Asian, Pacific Islander Teens With Overweight, Obesity
Findings show some variation by Asian subgroup
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs
